A carregar...

Effects of BACE1 Haploinsufficiency on APP Processing and Aβ Concentrations in Male and Female 5XFAD Alzheimer Mice at Different Disease Stages

β-Site APP-cleaving enzyme 1 (BACE1) initiates the generation of amyloid-β (A β), thus representing a prime therapeutic target for Alzheimer’s disease (AD). Previous work including ours has used BACE1 haploinsufficiency (BACE1(+/−); i.e., 50% reduction) as a therapeutic relevant model to evaluate th...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuroscience
Main Authors: Devi, Latha, Ohno, Masuo
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4591236/
https://ncbi.nlm.nih.gov/pubmed/26314636
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neuroscience.2015.08.037
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!